- Conditions
- Uncontrolled Hypertension
- Interventions
- RTN-001, Matching placebo control
- Drug
- Lead sponsor
- Retension Pharmaceuticals. Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 280 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 34
- States / cities
- Alexander City, Alabama • Birmingham, Alabama • Tucson, Arizona + 30 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 241–264
of 3,906
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Inflammation, Cancer, Pain, Hypertension
- Interventions
- Sulindac
- Drug
- Lead sponsor
- Stony Brook University
- Other
- Eligibility
- Up to 75 Years · Female only
- Enrollment
- 114 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2019
- U.S. locations
- 2
- States / cities
- Tucson, Arizona • Stony Brook, New York
- Conditions
- Hypertension (HTN), Chronic Stress
- Interventions
- Behavioral: B-MORE (Brief Mindfulness-Oriented Recovery Enhancement)
- Behavioral
- Lead sponsor
- Florida State University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Orlando, Florida
- Conditions
- Aging, Arterial Stiffness, Endothelial Dysfunction, Hypertension, Cognitive Decline
- Interventions
- Experimental: Nitrate-containing, Placebo: Nitrate-depleted
- Drug
- Lead sponsor
- Gary L. Pierce, PhD
- Other
- Eligibility
- 50 Years to 79 Years
- Enrollment
- 16 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2024
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
- Conditions
- RV - Right Ventricular Abnormality, LV Dysfunction, Pulmonary Hypertension, TOF
- Interventions
- Not listed
- Lead sponsor
- HBI Solutions Inc.
- Industry
- Eligibility
- Up to 18 Years
- Enrollment
- 3,993 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2024
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Venous Hypertension Ulcers, Venous Stasis Ulcer, Venous Ulcer, Venous Insufficiency, Leg Ulcer, Foot Ulcer, Varicose Ulcer, Diabetic Foot
- Interventions
- Cooling gel pack, Cooling cotton pack
- Device
- Lead sponsor
- Medical University of South Carolina
- Other
- Eligibility
- 50 Years and older
- Enrollment
- 140 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2020
- U.S. locations
- 2
- States / cities
- Charleston, South Carolina • Spartanburg, South Carolina
- Conditions
- Coronary Arteriosclerosis
- Interventions
- Not listed
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- NIH
- Eligibility
- Not listed
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2003
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Pulmonary Arterial Hypertension (PAH)
- Interventions
- Tiprelestat (5 mg), Placebo (1 mL 0.9% saline solution), Tiprelestat (10 mg)
- Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 10
- States / cities
- Tucson, Arizona • San Francisco, California • Stanford, California + 7 more
- Conditions
- Hypertension, Diabetes Type 2
- Interventions
- Aliskiren, Hydrochlorothiazide
- Drug
- Lead sponsor
- Corewell Health East
- Other
- Eligibility
- 18 Years to 85 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2012
- U.S. locations
- 1
- States / cities
- Royal Oak, Michigan
- Conditions
- Glaucoma, Tumors, Age-Related Macular Degeneration
- Interventions
- high frequency ultrasound examination
- Procedure
- Lead sponsor
- Weill Medical College of Cornell University
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 150 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 1996 – 2010
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Hypertension, Diabetes Mellitus
- Interventions
- CVRS Intervention
- Behavioral
- Lead sponsor
- Korey Kennelty
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 542 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2024
- U.S. locations
- 14
- States / cities
- Pocatello, Idaho • Chicago, Illinois • Mahomet, Illinois + 11 more
- Conditions
- Prehypertension (elevated Blood Pressure) or Hypertension
- Interventions
- H1 receptor blockade: 540 mg (Allegra), H2 receptor blockade: 40 mg (Pepcid AC)
- Genetic
- Lead sponsor
- California Baptist University
- Other
- Eligibility
- 18 Years to 30 Years · Male only
- Enrollment
- 10 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024
- U.S. locations
- 1
- States / cities
- Riverside, California
- Conditions
- Ocular Hypertension, Open-Angle Glaucoma
- Interventions
- Latanoprost Punctal Plug Delivery System (L-PPDS)
- Drug
- Lead sponsor
- Mati Therapeutics Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 86 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2016
- U.S. locations
- 18
- States / cities
- Chandler, Arizona • Phoenix, Arizona • Torrance, California + 15 more
- Conditions
- Metabolic Syndrome
- Interventions
- Grape Seed Extract, Placebo
- Dietary Supplement
- Lead sponsor
- University of California, Davis
- Other
- Eligibility
- 20 Years to 70 Years
- Enrollment
- 19 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 1
- States / cities
- Mather, California
- Conditions
- Pregnancy; Proteinuria, With Hypertension (Severe Pre-eclampsia), Delivery; Proteinuria, With Gestational Hypertension (Pre-eclampsia, Severe), Pregnancy; Hypertension, Gestational Hypertension, With Albuminuria (Severe Pre-eclampsia)
- Interventions
- Not listed
- Lead sponsor
- University of Mississippi Medical Center
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 1
- States / cities
- Jackson, Mississippi
- Conditions
- HIV
- Interventions
- MRI, L-NMMA, Acetylcholine
- Procedure · Drug
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Exfoliation Syndrome, Primary Open Angle Glaucoma, Cataracts
- Interventions
- anterior segment OCT
- Device
- Lead sponsor
- Duke University
- Other
- Eligibility
- 40 Years and older
- Enrollment
- 4 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Pulmonary Arterial Hypertension
- Interventions
- treprostinil diethanolamine
- Drug
- Lead sponsor
- United Therapeutics
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- Started 2010
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Blood Pressure
- Interventions
- Potassium Chloride, Placebo
- Dietary Supplement · Other
- Lead sponsor
- Tulane University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- New Orleans, Louisiana
- Conditions
- Glaucoma, Ocular Hypertension, Ocular Surface Disease
- Interventions
- Latanoprost, Travatan Z
- Drug
- Lead sponsor
- Santen SAS
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 105 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 1
- States / cities
- Andover, Massachusetts
- Conditions
- Acute Respiratory Distress Syndrome, Pulmonary Hypertension
- Interventions
- Nitric Oxide
- Drug
- Lead sponsor
- Yuri Matusov
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Hypertension
- Interventions
- Lifelight, Manual sphygmomanometer
- Device
- Lead sponsor
- Xim Limited
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 85 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023
- U.S. locations
- 1
- States / cities
- Louisville, Colorado
- Conditions
- Hypertension
- Interventions
- ALN-AGT01 RVR, Placebo, Zilebesiran
- Drug
- Lead sponsor
- Alnylam Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 93 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 3
- States / cities
- Lake Forest, California • Tampa, Florida • Savannah, Georgia
- Conditions
- Renal Artery Obstruction, Kidney Disease
- Interventions
- MRI
- Procedure
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- NIH
- Eligibility
- Not listed
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2005
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland